ArticleMolecular diversity2026

Evaluation of toll-like receptor inhibition by novel thymoquinone analogues as potential remedy for diabetic nephropathy.

Nashwa H Zaher et al.PubMed ↗Publisher ↗

No numbers read from the abstract.